Clinical Trial Update: Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating cetuximab, carboplatin, and paclitaxel followed by radiation therapy, with or without cisplatin, in metastatic head and neck c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-04-05